References
- McBride C. M. Management of malignant melanoma. Adv. Surg. 1974; 8: 129–150
- Gutterman J. V., McBride C., Freireich E. J., et al. Active immunotherapy with BCG for recurrent malignant melanoma. Lancet 1973; i: 1208–1212
- Lewis M. G., Ikonopisov R. L., Nairn R. C. Tumour specific antibodies in human malignant melanoma and their relationship to the extent of the disease. Br. Med. J. 1969; 3: 547–552
- Cottier H., Turk J., Sobin L. A. Proposal for a standardized system of reporting human lymph node morphology in relation to immunological function. J. Clin. Pathol. 1973; 26: 317–331
- Chalkley H. W. Method for the quantitative morphologic analysis of tissues. J. Natl. Cancer. Inst. 1943; 4: 47–53
- Pihl E., Malahy M. A., Khankhanian N., et al. Immunomorphologic features of prognostic significance in colorectal carcinoma. Cancer Res. 1977; 37: 4145–4149
- Pihl E., Nairn R. C., Hughes E. S. R., et al. Regional lymph node and stromal immunomorphology in colorectal carcinoma and relation to tumour spread. Pathology 1980; 12: 15–21
- Gehan E. A. A generalized Wilcoxon test for comparing arbitrarily single censored samples. Biometrika 1965; 52: 203–223
- Wilkinson E. J., Hause L. Probability in lymph node sectioning. Cancer 1974; 33: 1269–1274
- Pihl E., Nairn R. C., Milne B. J., et al. Lymphoid hyperplasia: A major prognostic feature in 519 cases of colorectal carcinoma. Am. J. Pathol. 1980; 100: 469–480